Nasal septum perforation in a breast cancer patient treated with bevacizumab. [electronic resource]
Producer: 20100108Description: 1901-2 p. digitalISSN:- 1569-8041
- Adult
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bevacizumab
- Breast Neoplasms -- drug therapy
- Female
- Humans
- Mastectomy
- Nasal Septum -- pathology
- Neoplasm Recurrence, Local -- drug therapy
- Neoplasm Staging
- Nose Diseases -- chemically induced
- Radiotherapy
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.